Before meeting up with me for dinner to celebrate my first time in Korea, my Seoul-based friend Jessica got off the plane after a business trip in Los Angeles and drove straight to her dermatologist or "dermie," as she affectionately calls him for Botox on her nose and jawline. After our stomachs were filled with dak galbi and soju, I scooted closer to Jessica in our booth and asked her about her latest dermie appointment. She began to list the dozen-plus cosmetic procedures she's tried since moving to Seoul from New York City eight years ago. Botox was her gateway injectable, starting with her jawline for a narrower, V-shaped silhouette. Since then, Jessica's gotten fillers in her forehead, chin, nose, and lips.
She also mentioned the "Chanel" injection, a cocktail of vitamins, minerals, and antioxidants that is supposed to tighten and brighten skin (she didn't notice a difference, though). I listened to all of this slightly slack-jawed. On the other side of Jessica was our friend who grew up in South Korea he was utterly unfazed. There, the idea of a 33-year-old signing up for regular cosmetic injections is par for the course. An estimated one in three South Korean women between the ages of 19 and 29 has undergone a cosmetic procedure, according to a 2015 Gallup poll.
Earlier in the week, I skipped Seoul's stunning palaces and animal-cafe tourist traps to go straight to Gangnam. The neighborhood's streets are lined with high-rises filled with full-service, multilevel plastic surgery and dermatology clinics, many complete with in-house pharmacies, stem cell laboratories, and hotel rooms for out-of-towners. Hundreds of people cycle in and out daily for touch-ups and treatments, with the nonchalance of stopping by a salon for a blowout. Inside these buildings, the future of injectables is being determined by a discerning audience of South Koreans who prize flawless skin, small faces, and round, youthful features. To maximize efficacy and move patients along, the spaces are divided by treatment (like the "filler room" in one clinic I visited, where chairs are lined up for patients to receive their injections, one next to the other). And unlike in the U.S., where privacy surrounding cosmetic work is prized, waiting rooms are sprinkled with patients wearing a full face of numbing cream as they stand by for their cosmetic procedures.
I met with Korean doctors who spoke very casually of thread-lifting vaginas or injecting Botox into the calves, applications I had never heard of (or even imagined).
In the U.S., we have 32 FDA-approved dermal fillers. It can take many years of testing (and bureaucracy) for a new one to see the light of a doctor's office. In South Korea, however, regulation is less stringent, and a person looking for injectables in Seoul has many more options to choose from. Formulas that the FDA has not approved because of a lack of studies on efficacy and safety or potentially serious side effects, like injectable skin-brighteners spiked with glutathione (an antioxidant that can deactivate the body's melanin-producing enzymes), are used regularly in Korea. And while American doctors certainly use neurotoxins and hyaluronic acid fillers off-label (injecting Botox to lift lips, for example), I met with Korean doctors who spoke very casually of thread-lifting vaginas or injecting Botox into the calves, applications I had never heard of (or even imagined).
"It's common for Koreans to go to the dermatologist weekly, sometimes even daily, for maintenance treatments."
When it comes to the latest trends and technology in injectables, Seoul is ahead of the curve. "A lot of Korean [patients] are first-time adopters," says Yongjoon Noh, a plastic surgeon at Banobagi Plastic Surgery & Aesthetic Clinic in Seoul. "New fillers, new materials, new plastic surgery techniques they want to try them all." A big upside to all this: With so many options available, cosmetic injections are vastly cheaper in Korea than they are in the U.S. Alternatives to Botox, like Medytox and Botulax, can be priced as low as $30 for a treatment (compared to about $400 in the U.S.). "It's common for Koreans to go to the dermatologist weekly, sometimes even daily, for maintenance treatments," says Y. Claire Chang, a New York City-based dermatologist who frequently travels to Seoul to learn about the latest advancements in cosmetic dermatology.
Many of the most popular injectable techniques are specific to Korean beauty standards: plump apples of the cheeks and rounded foreheads, as well as the aforementioned V-shaped jawlines. But other techniques, like using Botox to create the impression of poreless skin, or a thin hyaluronic acid filler to softly upturn the corners of the mouth, are likely to start creeping into practices in the U.S. in fact, they've already arrived in some. Want to know what's on the horizon? During my week in Korea, these were the procedures I heard about over and over again.
"Glass skin" is the Korean ideal of a poreless, translucent complexion (like a pane of glass). And the key to getting it is meso-Botox (or colloquially, "skin Botox"). For years, Korean celebrities have sworn by these shallow injections, especially before major events, says Shin Hye Won, a dermatologist at Oracle Clinic in Seoul. Just a few miles east, at Thema Dermatologic Clinic, they have 30 to 40 patients a day who undergo the procedure, says dermatologist Lim Ee Seok. The cost? About $300. (In the U.S., Chang offers it for $950 to $1,200.) Rather than being injected into the muscles to prevent and smooth wrinkles, botulinum toxin is placed just below the skin's surface, at about 40 to 50 sites along the jawline, forehead, and undereye areas. As a result, pores tighten, which makes skin appear smoother and brighter, and excessive acne-causing sebum stops forming. The effects last between three and four months.
The fruity nickname is a reference to the lip shape this filler technique creates. In the past, Angelina Jolie's lips were the most requested look in Seoul (just as they were in the U.S.), says Kang Jong Bum, a dermatologist at JY Plastic Surgery & Dermatology in Seoul. But as of 2019, Koreans prefer the more targeted plumping that many K-pop stars are known for. Instead of giving lips an allover fullness, dermatologists administer a hyaluronic acid filler (like Juvederm or Restylane, or domestic options Yvoire or Neuramis) to the middle areas of the upper and lower lip, enhancing the Cupid's bow. Imagine two double-stemmed cherries on their sides, the stems forming the outline of the edges of your smile. The results last for at least six months and cost about $150 to $250 in Korea.
After the center of the lips are plumped, the same hyaluronic acid filler is often administered just above the outer corners of the mouth a technique called lift edge filler. As the name suggests, the treatment raises the edges of the lips into a soft smile. As we age, the area around our mouth loses volume, and the outer corners start falling into an unintentional frown. Lift edge filler counters the droop and balances out all that fruity volume in the center of the lips, explains Kang.
"It's really popular here for people with resting bitch face. It helps them look softer."
My best friend, CJ, who lives in Gangnam and works in the K-pop industry, knows people who get the procedure for other reasons. "It's really popular here for people with resting bitch face," she says. "It helps them look softer." Like other lip injections, lift edge filler lasts about six months to a year; swelling and small bumps can result, usually for two to three days after the injection, before dissolving. Banobagi offers a cherry lip filler and lifts edge filler combination. A permanent smile is also trending in South Korea. One of the coordinators at JY Plastic Surgery & Dermatology mentioned increased requests for surgical smile lifts, where surgeons create incisions in the same areas targeted by lift edge filler, so your face rests naturally with the corners turned up.
My Korean is limited, but I do know the word for thread lift (also, not to brag, egg and grandpa). And that was a good thing because the term came up often in my reporting. At one point, Kang asked if I wanted to try a thread lift myself. I'm 27, with skin that is more plump than saggy, so I was extremely confused by the offer. Thread lifts in Korea, Kang clarified, are not the "facelift lites" that we consider them here.
"We use thread lifting to make it look like a patient has had a nose job without actually doing a nose job,"
Sure, the mechanics of thread lifts in Korea are the same as they are in the U.S.: Dissolvable, fine-barbed threads are passed underneath the skin with a large needle. Then, as the needle is pulled out, the barbs grab onto skin and pull it upward, stimulating collagen and tightening and lifting the skin. Korean-style thread lifts, though, are less invasive because finer threads are used; they alter the shape of the face, slimming the jawline or changing the contours of the nose.
"We use thread lifting to make it look like a patient has had a nose job without actually doing a nose job," says Choi Jun Young, the lead plastic surgeon at JY Plastic Surgery & Dermatology, of his most requested thread lift procedure. The thread is injected between the nostrils, and in about 15 minutes patients can walk out with the bridge and tip of their nose angled higher. The results last around a year or two and run about $250 to $420.
"These days, it's not about fixing a problem but preventing it," says Lim. He believes the future of cosmetic dermatology in Korea is the "booster shot," an injection designed to rev up skin's natural powers of regeneration and moisturize and brighten skin not to change the contours of your face.
The most sought-after booster shot at JY is Jalupro, a solution of amino acids and sodium hyaluronate (a form of hyaluronic acid) manufactured in Switzerland. Kang says it builds up collagen (to best effect when done as a series of injections over several weeks), so the skin becomes plumper and acne scars start to fade away. Jalupro can be injected all over your face, but Kang likes to target wrinkle-prone areas like the forehead, around the mouth, and around the eyes. It can also supplement laser treatments for stretch marks. My friend Jessica loved the results so much that she got it once a week for three months.
Rejuran which contains PDRN, short for polydeoxyribonucleotide is the booster shot that many doctors in Korea believe holds the most promise. PDRN is extracted from a segment of salmon DNA that is a 95 percent match to that of humans. This small DNA chain is known for its anti-inflammatory and tissue-repairing properties. When injected into the skin, Rejuran is said to shrink pores, diminish the appearance of fine lines and wrinkles, even skin tone, and balance oil production. Unlike skin Botox, which focuses on instantly smoothing the surface, PDRN could heal sun damage or acne overtime at the cellular level, based on early in vitro research. Typically, patients get three monthly injections ($100 to $340 each), for results that last up to a year.
Read more about injectables:
Now, watch a dermatologists entire skin-care routine:
Follow Devon Abelman on Twitter and Instagram.
Originally Appeared on Allure
- Blood drive to honor Franklin child with cancer - Daily Journal - January 24th, 2020
- UAB scientist studies aging through gray hair, says hair could be rejuvenated - AL.com - January 24th, 2020
- Advancells Group & IFC Concluded their 3-Day Workshop on Regenerative Medicine - MENAFN.COM - January 24th, 2020
- How will technology shape and disrupt our health care this decade? - Times Union - January 24th, 2020
- Major name scheduled to be in Houston for WWE Royal Rumble PPV - Wrestling News - January 24th, 2020
- LifeCell launches 'Genome-Scope' newborn genetic testing to diagnose over 4000 genetic conditions - Yahoo India News - January 24th, 2020
- Advancells Group, IFC concluded their three-day workshop on Regenerative Medicine - Yahoo India News - January 24th, 2020
- New York-based hair restoration company opens new office in New Jersey - amNY - January 24th, 2020
- Orgel, others push city for help with loss of HealthPlus pool - Auburn Villager - January 24th, 2020
- Advancells Group & IFC Concluded their 3-Day Workshop on Regenerative Medicine - Business Wire India - January 23rd, 2020
- Biodegradable tube excels at treatment of nerve injuries - New Atlas - January 23rd, 2020
- European Commission Approves Darzalex (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diag -... - January 23rd, 2020
- Breakthrough discovery could lead to one-size-fits-all cancer treatment - The Independent - January 23rd, 2020
- Illumia Therapeutics, Singapore's Latest Full-Service Medispa, Lets You Address Your Beauty And Wellness Needs In One Place - Singapore Tatler - January 23rd, 2020
- Misplaced Assumptions, Where Investments Go Wrong - Seeking Alpha - January 23rd, 2020
- Learning to be relentless - The Daily Republic - January 19th, 2020
- Here's Why Stemline Therapeutics Dropped Today - Motley Fool - January 19th, 2020
- Medics key to spotting signs of child abuse, Abu Dhabi conference hears - The National - January 19th, 2020
- Smart Group & A4M Concluded their First India Conference 2020 - NewsPatrolling - January 19th, 2020
- 'Comfort' or con? Despite money, education, well-off Filipinos turning to questionable treatments - Coconuts - January 13th, 2020
- Doctor's Hospital focused on incorporation of AI and machine learning - EyeWitness News - January 13th, 2020
- Viewpoints: Medicaid Expansion Reveals How Liberal Policies Make For Good Politics; Hey, Congress, What's The Hold Up With Surprise Medical Bills? -... - January 13th, 2020
- White blood cells: Function, ranges, types, and more - Medical News Today - January 10th, 2020
- Tacitus Therapeutics Launches in Collaboration with Mount Sinai to Develop Stem Cell Therapies for Life-Threatening Diseases - PRNewswire - January 10th, 2020
- Tip Sheet: Mesh loaded with T cells shrinks tumors; second dose of CAR-T cells shows potential; and gene-edited cells stay safe as immunotherapy... - January 10th, 2020
- 3D-printed Organs Give Hope to Transplant Patients Now. Powered by - Now. Powered by Northrop Grumman. - January 10th, 2020
- Seattle Childrens faces widening array of lawsuits over fatal mold infections - Seattle Times - January 10th, 2020
- Landisa: My cancer can relapse but here's why I am not afraid of it any longer - News24 - January 10th, 2020
- 'You wouldn't give it to your worst enemy': what it's like to live with Lyme disease - Telegraph.co.uk - January 10th, 2020
- The 'supercells' that cured an infant's grave genetic illness - Japan Today - January 10th, 2020
- Edited Transcript of BYSI.OQ earnings conference call or presentation 18-Dec-19 1:00pm GMT - Yahoo Finance - January 8th, 2020
- How These Practitioners Can Help with New Year, New You Goals - Milwaukee Magazine - January 7th, 2020
- Summerside gym needs donations for three-year-old boy with cancerous brain tumors - The Journal Pioneer - January 7th, 2020
- The woman who spent 7 years in and out of hospital battling rare condition some doctors had never seen - Leicestershire Live - January 7th, 2020
- West Norwood girl, 3, dies in her parents' arms after brave battle with leukaemia - MyLondon - January 7th, 2020
- DuPont, C8 Contamination And The Community Left To Grapple With The Consequences - WVXU - January 7th, 2020
- What are the odds? Stem cell recipient learns her donor is also in Ottawa - Ottawa Citizen - January 3rd, 2020
- Understanding the Key Aspects of a Multiple Myeloma Diagnosis - Curetoday.com - January 3rd, 2020
- The 'supercells' that cured an infant's grave genetic illness - FRANCE 24 - January 3rd, 2020
- How supercells cured an infants grave genetic illness - Raw Story - January 3rd, 2020
- Firm adds a new wrinkle to anti-aging products - Williamson Daily News - January 3rd, 2020
- First Edition: January 3, 2020 - Kaiser Health News - January 3rd, 2020
- Finn the Fabulous to ring treatment bell after leaving hospital - expressandstar.com - January 3rd, 2020
- Conway supports man fighting rare double diagnosis of MS, ALS - THV11.com KTHV - January 1st, 2020
- Predicting shifts in technology and science can be tricky, but here's what could happen in 2020 - inews - January 1st, 2020
- None of these four beaming children would be alive today if a stranger had not given blood - The Sun - January 1st, 2020
- On the Road: A year to remember - WCBI - January 1st, 2020
- 2019: the year gene therapy came of age - Breitbart - January 1st, 2020
- The health stories we won't forget and what 2020 holds - nation.co.ke - January 1st, 2020
- Chinese scientist who claimed he genetically edited babies gets prison term - Los Angeles Times - December 30th, 2019
- Year in Review: Gene Therapy Technology and a Milestone 2019 for Medical Research - News18 - December 30th, 2019
- Finding Joy While Struggling With Infertility Over The Holidays - SheKnows - December 25th, 2019
- The reporter driven to do 'whatever it takes' to conquer cancer and return to the press box - The Athletic - December 25th, 2019
- A blood cancer diagnosis helped me find true happiness - The Guardian - December 25th, 2019
- Michael Schumacher health: Doctor reveals truth about Schumi as Lewis Hamilton is catching up fast to break F1 legend's record - EconoTimes - December 25th, 2019
- Mother and son, together, cope with autism and multiple sclerosis - MLive.com - December 25th, 2019
- Local firm adds a new wrinkle to anti-aging products - Williamson Daily News - December 25th, 2019
- Miracle recovery of rider and her horse after severe injuries - Yorkshire Post - December 25th, 2019
- Before the 90 Days Stephanie is YouTuber Stepanka. Is she really ill & bi? - Starcasm - December 21st, 2019
- Stem Cell Therapy Treatment - Melbourne Stem Cell Centre - December 10th, 2019
- U.S. Stem Cell Training | Regenerative Medicine Training ... - December 10th, 2019
- ASH 2019 Roundup: The Latest on CAR T, New Treatments for CLL, and Using Genes to Predict a Common Side Effect - On Cancer - Memorial Sloan Kettering - December 10th, 2019
- Orgenesis and Theracell to Launch Point of Care Cell and Gene Therapy Centers within HYGEIA Group's Hospital Network in Greece - GlobeNewswire - December 10th, 2019
- 2019: The year gene therapy came of age - Jamaica Observer - December 10th, 2019
- Ethan's Army gets a boost - Brockville Recorder and Times - December 10th, 2019
- BREAKING: Baby body parts criminal trial to proceed against Daleiden with possible jail time - Lifesite - December 7th, 2019
- 'I was given a terminal diagnosis and then a new therapy cured my leukaemia' - The Telegraph - December 5th, 2019
- Stem Cell Therapy Market Robust pace of Industry during 2017-2025 - News Description - December 5th, 2019
- A #ReUp of 2019: The year when gene therapy, DNA modifications came of age & saved lives - Economic Times - December 5th, 2019
- 100 greatest innovations of 2019: Best of What's New - Popular Science - December 3rd, 2019
- Susan J. Demas: Right-wing lies on abortion paved the way for Trump - Michigan Advance - December 3rd, 2019
- Alum's New Book Recounts His Fight to Help First Responders Sickened after 9/11 - BU Today - December 3rd, 2019
- Quinn Waters: Weymouth, Massachusetts three-year-old is seeing the world for himself - CBS News - December 2nd, 2019
- 'We didn't worry when 2-year-old refused to use potty - then her lips went blue' - Mirror Online - December 2nd, 2019
- Upstate SC toddler survives rare cancer and the risky procedure used to treat it - Greenville News - December 2nd, 2019
- 13 YEAR OLD BOY WHO SURVIVED RARE CHILDHOOD CANCER TWICE SUPPORTS NEW FUNDRAISING CAMPAIGN - MENAFN.COM - December 2nd, 2019
- Heartbreaking photograph shows the reality of childhood cancer - Yahoo News - December 2nd, 2019
- Family releases photo sharing the reality of childhood cancer - NEWS.com.au - December 2nd, 2019
- "For the first time in 25 years this means hope" - Leeds family fundraising for life-changing MS treatment - Yorkshire Post - December 2nd, 2019
- Calgary MP won't give up effort to add donor consent option to tax forms - Calgary Herald - December 2nd, 2019